• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在过去的 30 年中,瑞典西部原发性醛固酮增多症的发病率不断增加——但仍未得到充分诊断。

Increasing Incidence of Primary Aldosteronism in Western Sweden During 3 Decades - Yet An Underdiagnosed Disorder.

机构信息

Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg and The Department of Endocrinology, Sahlgrenska University Hospital, SE-413 45, Gothenburg, Sweden.

Department of Internal Medicine, Northern Älvsborg County Hospital, SE-461 85, Trollhättan, Sweden.

出版信息

J Clin Endocrinol Metab. 2021 Aug 18;106(9):e3603-e3610. doi: 10.1210/clinem/dgab327.

DOI:10.1210/clinem/dgab327
PMID:33974052
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8372665/
Abstract

CONTEXT

Primary aldosteronism (PA) is the most common cause of secondary hypertension. Yet, the incidence of PA in the general population has not been studied.

OBJECTIVE

To estimate the incidence of PA in the general population.

DESIGN AND METHODS

Patients who had received a diagnostic code for PA between 1987 and 2016 were identified in the Swedish National Patient Registry. Assessment of clinical and biochemical data was used to validate the diagnosis. The annual incidence of PA was calculated by using the number of inhabitants in the Västra Götaland County as a reference.

RESULTS

Of 570 identified patients, 473 (83%) had confirmed PA. Eligible for the incidence analysis were 416 patients, 248 (60%) men and 168 (40%) women, diagnosed with PA between 1987 and 2016. The mean (± standard deviation) age at diagnosis was 56 ± 12 years. The median (interquartile range) annual incidence was 2 (1-2) cases per million between 1987 and 1996, 6 (4-9) cases per million between 1997 and 2006 and 17 (12-24) cases per million between 2007 and 2016. At the end of the study (December 31, 2016), 386 patients with confirmed PA were alive and living in the Västra Götaland County, giving a prevalence of 231 cases per million (0.022%).

CONCLUSIONS

Despite increasing incidence, the proportion of patients identified with PA is lower than expected. Given the serious consequences of untreated PA, the noticeably low prevalence at the end of the study stresses the need to increase the awareness of PA among health care providers.

摘要

背景

原发性醛固酮增多症(PA)是继发性高血压的最常见病因。然而,一般人群中 PA 的发病率尚未得到研究。

目的

估计一般人群中 PA 的发病率。

设计和方法

在瑞典国家患者登记处确定了 1987 年至 2016 年期间接受过 PA 诊断代码的患者。使用临床和生化数据评估来验证诊断。PA 的年发病率通过使用西约塔兰县的居民人数作为参考来计算。

结果

在确定的 570 例患者中,有 473 例(83%)被确认为 PA。有资格进行发病率分析的是 416 例患者,其中 248 例(60%)为男性,168 例(40%)为女性,他们在 1987 年至 2016 年间被诊断为 PA。诊断时的平均(±标准差)年龄为 56±12 岁。1987 年至 1996 年期间,每年每百万人中有 2(1-2)例,1997 年至 2006 年期间每年每百万人中有 6(4-9)例,2007 年至 2016 年期间每年每百万人中有 17(12-24)例。在研究结束时(2016 年 12 月 31 日),386 例确诊为 PA 的患者仍在世并居住在西约塔兰县,患病率为每百万人 231 例(0.022%)。

结论

尽管发病率不断上升,但确定的 PA 患者比例低于预期。鉴于未经治疗的 PA 会带来严重后果,研究结束时明显较低的患病率强调了提高医疗保健提供者对 PA 的认识的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b318/8372665/4e023ace008e/dgab327f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b318/8372665/43018f18d2cb/dgab327f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b318/8372665/ff49c8f551b0/dgab327f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b318/8372665/4e023ace008e/dgab327f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b318/8372665/43018f18d2cb/dgab327f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b318/8372665/ff49c8f551b0/dgab327f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b318/8372665/4e023ace008e/dgab327f0003.jpg

相似文献

1
Increasing Incidence of Primary Aldosteronism in Western Sweden During 3 Decades - Yet An Underdiagnosed Disorder.在过去的 30 年中,瑞典西部原发性醛固酮增多症的发病率不断增加——但仍未得到充分诊断。
J Clin Endocrinol Metab. 2021 Aug 18;106(9):e3603-e3610. doi: 10.1210/clinem/dgab327.
2
Ten year age- and sex-specific temporal trends in incidence and prevalence of heart failure in Västra Götaland, Sweden.瑞典哥德堡地区年龄和性别特异性心力衰竭发病率和患病率的 10 年时间趋势。
ESC Heart Fail. 2022 Dec;9(6):3931-3941. doi: 10.1002/ehf2.14103. Epub 2022 Aug 11.
3
The incidence rate of pituitary adenomas in western Sweden for the period 2001-2011.2001-2011 年期间瑞典西部垂体腺瘤的发病率。
Eur J Endocrinol. 2014 Oct;171(4):519-26. doi: 10.1530/EJE-14-0144. Epub 2014 Aug 1.
4
Letter to the Editor From Singhania et al: "Increasing Incidence of Primary Aldosteronism in Western Sweden During 3 Decades-Yet an Underdiagnosed Disorder".辛格尼亚等人致编辑的信:“瑞典西部原发性醛固酮增多症发病率在三十年中持续上升——仍是一种诊断不足的疾病”
J Clin Endocrinol Metab. 2022 Feb 17;107(3):e1315-e1316. doi: 10.1210/clinem/dgab804.
5
Prevalence of primary aldosteronism in primary care: a cross-sectional study.原发性醛固酮增多症在基层医疗中的流行情况:一项横断面研究。
Br J Gen Pract. 2018 Feb;68(667):e114-e122. doi: 10.3399/bjgp18X694589. Epub 2018 Jan 15.
6
Response to Letter to the Editor From Singhania et al.: "Increasing Incidence of Primary Aldosteronism in Western Sweden During 3 Decades - Yet an Underdiagnosed Disorder".对辛哈尼亚等人致编辑信的回复:“瑞典西部30年间原发性醛固酮增多症发病率上升——仍是一种诊断不足的疾病”
J Clin Endocrinol Metab. 2022 Feb 17;107(3):e1325-e1326. doi: 10.1210/clinem/dgab805.
7
Primary aldosteronism and thyroid disorders in atrial fibrillation: A Swedish nationwide case-control study.原发性醛固酮增多症与心房颤动中的甲状腺功能紊乱:一项瑞典全国范围内的病例对照研究。
Eur J Prev Cardiol. 2018 May;25(7):694-701. doi: 10.1177/2047487318759853. Epub 2018 Feb 23.
8
Prevalence of Primary Aldosteronism Across the Stages of Hypertension Based on a New Combined Overnight Test.基于新型联合过夜检测的原发性醛固酮增多症在高血压各阶段的患病率
Horm Metab Res. 2021 Jul;53(7):461-469. doi: 10.1055/a-1507-5226. Epub 2021 Jul 19.
9
Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice.原发性醛固酮增多症在基层医疗实践中的患病率和临床表现。
J Am Coll Cardiol. 2017 Apr 11;69(14):1811-1820. doi: 10.1016/j.jacc.2017.01.052.
10
Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan.原发性醛固酮增多症患者中心血管疾病及其危险因素的流行情况:日本多中心研究。
Hypertension. 2018 Mar;71(3):530-537. doi: 10.1161/HYPERTENSIONAHA.117.10263. Epub 2018 Jan 22.

引用本文的文献

1
A global real-world study assessing total time to adrenalectomy in primary aldosteronism.一项评估原发性醛固酮增多症患者肾上腺切除术总时长的全球真实世界研究。
Eur J Endocrinol. 2025 Jun 30;193(1):65-75. doi: 10.1093/ejendo/lvaf124.
2
Searching for peripheral proteomic markers of primary aldosteronism.寻找原发性醛固酮增多症的外周蛋白质组学标志物。
Endocrine. 2025 Jun 13. doi: 10.1007/s12020-025-04302-y.
3
Screening for primary aldosteronism in 1,181 Swedish primary care patients with hypertension.对1181名患有高血压的瑞典初级保健患者进行原发性醛固酮增多症筛查。
Front Endocrinol (Lausanne). 2025 Apr 14;16:1555572. doi: 10.3389/fendo.2025.1555572. eCollection 2025.
4
Serum microRNAs as peripheral markers of primary aldosteronism.血清微小RNA作为原发性醛固酮增多症的外周标志物。
Front Endocrinol (Lausanne). 2025 Mar 20;16:1511096. doi: 10.3389/fendo.2025.1511096. eCollection 2025.
5
Clinical practice guideline for the management of hypertension in China.《中国高血压防治临床指南》
Chin Med J (Engl). 2024 Dec 20;137(24):2907-2952. doi: 10.1097/CM9.0000000000003431. Epub 2024 Dec 9.
6
Hip fractures in patients with primary aldosteronism - a Swedish nationwide study.原发性醛固酮增多症患者的髋部骨折——一项瑞典全国性研究。
Osteoporos Int. 2024 Sep;35(9):1585-1593. doi: 10.1007/s00198-024-07132-2. Epub 2024 Jun 5.
7
Temporal trends in clinical features of patients with primary aldosteronism over 20 years.原发性醛固酮增多症患者 20 年临床特征的时间趋势。
Hypertens Res. 2024 Aug;47(8):2019-2028. doi: 10.1038/s41440-024-01703-w. Epub 2024 May 17.
8
Health Care Challenges in the Management of Primary Aldosteronism in Southeast Asia.东南亚原发性醛固酮增多症管理中的医疗保健挑战。
J Clin Endocrinol Metab. 2024 Jun 17;109(7):1718-1725. doi: 10.1210/clinem/dgae039.
9
Integration of clinical parameters and CT-based radiomics improves machine learning assisted subtyping of primary hyperaldosteronism.临床参数与 CT 影像组学相结合可改善基于机器学习的原发性醛固酮增多症亚型分类。
Front Endocrinol (Lausanne). 2023 Aug 24;14:1244342. doi: 10.3389/fendo.2023.1244342. eCollection 2023.
10
Specialty grand challenge in adrenal endocrinology.肾上腺内分泌学的专业重大挑战。
Front Endocrinol (Lausanne). 2023 Jul 6;14:1237733. doi: 10.3389/fendo.2023.1237733. eCollection 2023.